OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)

$11.45 -0.37 (-3.1303%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 87

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) News Sources

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.

15-05-2026

yahoo.com

Olema Oncology to Participate in Upcoming Investor Conferences

19-05-2026

yahoo.com

ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight

20-05-2026

yahoo.com

Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting

21-05-2026

yahoo.com

Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study

22-05-2026

stocktwits.com

Olema’s OP-3136 Data Draw Focus To Oncology Pipeline And Valuation Gap

25-05-2026

yahoo.com

Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer

26-05-2026

yahoo.com

How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet

17-06-2026

yahoo.com

Does Olema Pharmaceuticals' (OLMA) Broad Russell Growth Inclusion Reveal a Turning Point in Its Investor Story?

30-06-2026

yahoo.com

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02-07-2026

yahoo.com

OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) Sentiment Trend

0 25 50 75 100 76 89 90 77 91 90 89 92 91 86 15-05-2026 19-05-2026 20-05-2026 21-05-2026 22-05-2026 25-05-2026 26-05-2026 17-06-2026 30-06-2026 02-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) FAQs

toggle

What is the current price of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?

The current price of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is $11.45.


toggle

OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) absolute price change since previous trading day?

The absolute price change of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) since the previous trading day is $-0.37.


toggle

OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) percentage price change since previous trading day?

The percentage price change of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) since the previous trading day is -3.1303%.


toggle

What is the most recent average sentiment score for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?

The most recent average sentiment score for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is 87 out of 100.


toggle

What is the most recent average sentiment for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?

The most recent sentiment for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is .


SEC-8K** Filing Available For OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.